2021 Third quarter
We will announce our third quarter 2021 results at 12:00 BST, 07:00 EDT on Wednesday 27 October.
Following the announcement there will be a webcast hosted by Emma Walmsley, CEO, and other members of CET at 14:00 BST, 09:00 EDT.
2011 Second Quarter - released 26 July 2011
Andrew Witty, CEO, and Simon Dingemans, CFO, discuss our second quarter results 2011.
- Q2 reported sales -2%
- EPS before major restructuring* 25p
- Underlying sales growth of 5%
- Increased pipeline visibility and dividend of 16p, up 7%
2011 First Quarter - released 27 April 2011
Andrew Witty, CEO, discusses our first quarter results 2011.
- Reported sales -10%, underlying sales +4%
- EPS before major restructuring 32.2p (+9%), dividend 16p (+7%)
2010 Fourth Quarter - released 03 February 2011
Andrew Witty, CEO, discusses our fourth quarter results 2010.
2010 Third Quarter - released 21 October 2010
Andrew Witty, CEO, discusses our third quarter results 2010
- Q3 EPS before major restructuring of 28.2p
- Q3 dividend up 7% to 16p
Other key information
Speeches & presentations
Search through our archive of speeches and presentations from conferences and events
Keep up to date with our news and recent announcements
Corporate Executive Team
The Corporate Executive Team manages our activities, and each member is responsible for a specific part of the business
We invest in scientific and technical excellence to develop and launch a pipeline of new products that meet the needs of patients and payers